| Noah's Ark Learning Services | |
|
3129 Kenelm Drive Chesapeake VA 23323 | |
| (757) 828-3741 | |
| Not Available |
| Full Name | Noah's Ark Learning Services |
|---|---|
| Speciality | Community/behavioral Health |
| Location | 3129 Kenelm Drive, Chesapeake, Virginia |
| Authorized Official Name and Position | Delicia Perry-joseph (OWNER) |
| Authorized Official Contact | 7578283741 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Noah's Ark Learning Services 3419 Virginia Beach Blvd Virginia Beach VA 23452-4419 Ph: (757) 828-3741 | Noah's Ark Learning Services 3129 Kenelm Drive Chesapeake VA 23323 Ph: (757) 828-3741 |
| NPI Number | 1043802762 |
|---|---|
| Provider Enumeration Date | 02/04/2021 |
| Last Update Date | 03/25/2021 |
| Certification Date | 03/04/2021 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043802762 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | (* (Not Available)) | Primary |
News Archive
The GlaxoSmithKline 14th Annual IMPACT Awards target community-based nonprofits that provide access to healthcare for the underserved. Up to ten organizations in the Pennsylvania counties of Berks, Bucks, Chester, Delaware, Lancaster, Lehigh, Montgomery, and Philadelphia and the City of Camden, New Jersey, will be awarded $40,000 each.
A Washington Post editorial encouraging the U.S. to generously support Pakistan as it recovers from major flooding, states: the "humanitarian interest is heightened by Pakistan's centrality to America's national security interests. The Obama administration must seize this chance to deepen and broaden what is already a large commitment, lest Pakistan become even more of a breeding ground for terrorism."
A study published this week by ITG revealed that Novartis recently approved drug, Gilenya, has already taken share from market leaders in the multiple sclerosis (MS) market, and uptake is expected to increase significantly over the next year. Gilenya came onto the market in late September as the first FDA-approved oral disease-modifying MS drug, and Novartis initially faced safety concerns and monitoring requirements that deterred some physicians from adopting the new drug.
Today's headlines include reports about the health law's implementation and status checks on how the measure's online insurance marketplaces are taking shape.
Emory University today announced an innovative new public-private drug development enterprise that will transition scientific discoveries more rapidly and efficiently from university laboratories into the marketplace. The new venture is expected to provide global solutions to address worldwide drug development and commercialization needs.
› Verified 3 days ago
Covenant Way Clinical Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1545 Crossways Blvd, Chesapeake, VA 23320 Phone: 757-606-0971 | |
The Mule Group Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 840 Juniper Cres Ste 112, Chesapeake, VA 23320 Phone: 757-762-1831 | |
Miles Family Therapeutics Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 908 Kemp Xing, Chesapeake, VA 23320 Phone: 757-770-6360 | |
Innovative Counseling Solutions Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 118 Great Bridge Blvd, Chesapeake, VA 23320 Phone: 757-842-0542 | |
Pl Solutions Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1013 Sun Ave, Chesapeake, VA 23325 Phone: 757-264-1033 | |
All About You Residential Care, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 529 Cameo Ter, Chesapeake, VA 23320 Phone: 757-277-6586 | |
Hampton Roads Family Services Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1226 Progressive Dr Ste 202, Chesapeake, VA 23320 Phone: 631-291-8033 |